We are live on ! Find out more
SCP

Seizert Capital Partners Portfolio holdings

AUM $2.42B
1-Year Est. Return 22.12%
This Fund
S&P 500
This Quarter Est. Return
+6.84%
1 Year Est. Return
+22.12%
3 Year Est. Return
+73.42%
5 Year Est. Return
+88.59%
10 Year Est. Return
+355.73%
AUM
$2.31B
AUM Growth
+$33.1M
Cap. Flow
-$80.2M
Cap. Flow %
-3.48%
Top 10 Hldgs %
29.87%
Holding
187
New
15
Increased
41
Reduced
81
Closed
17

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$37.9M
2
COF icon
Capital One
COF
+$17.6M
3
QCOM icon
Qualcomm
QCOM
+$14M
4
CI icon
Cigna
CI
+$13.5M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$9.49M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$46.7M
2
AMGN icon
Amgen
AMGN
+$40.4M
3
PRGS icon
Progress Software
PRGS
+$39.5M
4
WCC
WESCO International
WCC
+$11.9M
5
JPM icon
JPMorgan Chase
JPM
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 22.73%
2 Financials 19.76%
3 Healthcare 17.74%
4 Industrials 13.62%
5 Consumer Discretionary 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MAS icon
26
Masco
MAS
$15.3B
$42.3M 1.83%
600,537
+1,550
+0.3% +$109K
DOX icon
27
Amdocs
DOX
$6.22B
$41.8M 1.81%
509,681
+1,490
+0.3% +$129K
ELV icon
28
Elevance Health
ELV
$85.5B
$41.3M 1.79%
127,826
-6,027
-5% -$1.87M
SSNC icon
29
SS&C Technologies
SSNC
$18.6B
$40M 1.73%
450,970
+70,524
+19% +$6.1M
WCC
30
WESCO International
WCC
$17.7B
$39.2M 1.7%
185,176
-56,591
-23% -$11.9M
BLDR icon
31
Builders FirstSource
BLDR
$8.04B
$36.6M 1.59%
301,836
+846
+0.3% +$112K
BMY icon
32
Bristol-Myers Squibb
BMY
$132B
$32.4M 1.41%
719,392
+6,604
+0.9% +$308K
ACI icon
33
Albertsons Companies
ACI
$5.83B
$32M 1.39%
1,828,935
+5,331
+0.3% +$105K
CCK icon
34
Crown Holdings
CCK
$13.1B
$29.7M 1.28%
307,002
+987
+0.3% +$99K
LDOS icon
35
Leidos
LDOS
$17.3B
$21M 0.91%
111,159
-10,459
-9% -$1.82M
RHI icon
36
Robert Half
RHI
$4.37B
$17.9M 0.77%
525,727
-1,496
-0.3% -$56.1K
META icon
37
Meta Platforms (Facebook)
META
$1.51T
$15.6M 0.67%
21,212
-2,211
-9% -$1.65M
CHKP icon
38
Check Point Software Technologies
CHKP
$13.1B
$15.5M 0.67%
75,088
-7,230
-9% -$1.46M
BRC icon
39
Brady Corp
BRC
$4.57B
$15.1M 0.66%
193,892
-14,569
-7% -$1.08M
GHC icon
40
Graham Holdings Company
GHC
$5.02B
$14.2M 0.61%
12,041
-238
-2% -$246K
MSFT icon
41
Microsoft
MSFT
$3.71T
$13.3M 0.58%
25,723
-3,275
-11% -$1.67M
FFIV icon
42
F5
FFIV
$22.7B
$13.1M 0.57%
40,658
-5,546
-12% -$1.74M
EXEL icon
43
Exelixis
EXEL
$13.4B
$12.1M 0.52%
291,862
-55,227
-16% -$2.22M
CVS icon
44
CVS Health
CVS
$122B
$11.4M 0.49%
150,792
-3,368
-2% -$231K
DCI icon
45
Donaldson
DCI
$11.4B
$11.3M 0.49%
137,674
+1,653
+1% +$125K
LRCX icon
46
Lam Research
LRCX
$390B
$10.5M 0.46%
78,716
-39,475
-33% -$4.18M
EME icon
47
Emcor
EME
$36B
$10.2M 0.44%
15,683
-5,503
-26% -$3.34M
FOXA icon
48
Fox Class A
FOXA
$26.9B
$10.1M 0.44%
160,449
-2,936
-2% -$170K
NBIX icon
49
Neurocrine Biosciences
NBIX
$16.6B
$9.83M 0.43%
+70,035
New +$9.49M
TROW icon
50
T. Rowe Price
TROW
$24.3B
$8.95M 0.39%
87,194
-38,255
-30% -$4.02M
1
2
3 4 5

Similar funds

PUI
Purpose Unlimited Inc Toronto $2.42B AUM
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
KFA
Krane Funds Advisors New York $2.44B AUM 12.99% 1-Year Est. Return
PA
Paralel Advisors Denver, Colorado $2.41B AUM 9.57% 1-Year Est. Return
QT
Quantbot Technologies New York $2.44B AUM 17.13% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
RG
Renaissance Group Covington, Kentucky $2.39B AUM 27.81% 1-Year Est. Return

Seizert Capital Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Seizert Capital Partners held 187 positions worth $2.31B, up 1.5% from $2.28B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Seizert Capital Partners withdrew a net $80.2M in Q3 2025, closing 17 positions and reducing 81 holdings. Its most notable exit was Progress Software, an estimated $39.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Seizert Capital Partners opened a new position in Neurocrine Biosciences worth $9.83M.

  • Seizert Capital Partners's largest Q3 2025 buy was Neurocrine Biosciences: 70,035 shares worth $9.83M.
  • Seizert Capital Partners added most to Adobe in Q3 2025, an estimated $37.9M increase.
  • Seizert Capital Partners's biggest Q3 2025 reduction was Bank of America, cutting an estimated $46.7M.
  • Seizert Capital Partners fully exited Progress Software in Q3 2025, selling an estimated $39.5M.
  • Seizert Capital Partners's ten largest holdings make up 30% of its $2.31B portfolio in Q3 2025.
  • Seizert Capital Partners opened 15 new positions and closed 17 in Q3 2025.
  • Seizert Capital Partners's portfolio value rose 1.5% quarter-over-quarter to $2.31B.

Based on Seizert Capital Partners's 13F filing for Q3 2025, filed 29 Oct 2025.